Efficient late-stage formation of aryl– 211 At bonds is relevant to expanding
the scope of targeted α-therapy radiopharmaceuticals. In this work, a catalyst-enabled
High-Yield Room-Temperature Aryl 211At Radiolabeling via Redox-Activated Column-Shipped 211At
Published: 06/18/2026
